CHEMOMAB THERAPEUTICS LTD's ticker is CMMB and the CUSIP is 16385C104. A total of 14 filers reported holding CHEMOMAB THERAPEUTICS LTD in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $129,000 | -22.8% | 35,024 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $167,000 | -35.5% | 35,024 | -6.8% | 0.00% | -50.0% |
| Q4 2021 | $259,000 | -37.7% | 37,567 | 0.0% | 0.00% | -42.9% |
| Q3 2021 | $416,000 | -73.1% | 37,567 | -53.8% | 0.01% | -65.0% |
| Q2 2021 | $1,546,000 | +546.9% | 81,328 | +878.6% | 0.02% | +185.7% |
| Q1 2021 | $239,000 | – | 8,311 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 2,241,274 | $2,005,940 | 0.04% |
| Ikarian Capital, LLC | 213,392 | $190,986 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 26,529 | $23,743 | 0.00% |
| KESTRA PRIVATE WEALTH SERVICES, LLC | 31,241 | $27,961 | 0.00% |
| Qube Research & Technologies Ltd | 44 | $39 | 0.00% |
| Moser Wealth Advisors, LLC | 500 | $448 | 0.00% |
| Newbridge Financial Services Group, Inc. | 1,100 | $985 | 0.00% |
| UBS Group AG | 141 | $126 | 0.00% |
| RHUMBLINE ADVISERS | 2,843 | $2,542 | 0.00% |
| OSAIC HOLDINGS, INC. | 1,775 | $1,587 | 0.00% |